Successful OCT imaging during cancer surgery

Entities Mentioned

• Massachusetts Institute of Technology
• Michelson Diagnostics
• Jon Holmes
• Wolfgang Drexler
• Cardiff University
• GE Healthcare
• European Society of Cardiology
• University College Hospital
• Imperial College London
• Gloucestershire Royal Hospital
• Tactiq Ltd
• Florian Bazant-Hegemark
• UK National Physical Laboratory
• Kamelian Ltd.
• Michelson Diagnostics EX1301

1. Michelson Diagnostics has been featured on the front page of European Hospital in the Medical special edition describing successful initial results from clinical testing of its Optical Coherence Microscope are described, along with details of MDL’s recent 900k€ early stage funding round and awards and grants received. (Read Full Article)

   Bookmark or Share this article

   
   

   Related Articles

   • Digital phase stabilization to improve detection sensitivity for optical coherence tomography
   • also mentions UK National Physical Laboratory
   • Lantis Laser's OCT System Addressing Increase in Tooth Decay
   • also mentions Massachusetts Institute of Technology
   • OCT market to top $800 million by 2012
   • also categorized in Funding
   • Multi-channel Fourier domain OCT system with superior lateral resolution for biomedical applications
   • also mentions Gloucestershire Royal Hospital
   • Lantis Laser (LLSR) Successfully Completes $2.5 Million Financing
   • also categorized in Funding

   • Optovue, an ocular disease treatment co., raises $10.5M
   • also categorized in Funding
   • Lantis Laser Successfully Completes $2.5 Million Financing
   • also categorized in Funding
   • Coronary bioabsorbable magnesium stent: 15-month intravascular ultrasound and optical coherence tomography findings
   • also mentions Imperial College London
   • GlucoLight Corporation Raises Second Tranche of ''c'' Round Financing
   • also categorized in Funding
   • Pioneering Cancer treatment technology backed by London Seed Capital
   • also categorized in Funding

Login to comment.